Infectious anterior uveitis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:279922H20.0H20.1H20.2
Who is this for?
Show terms as
30Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Infectious anterior uveitis is an inflammatory condition affecting the front portion of the uveal tract of the eye, specifically the iris and ciliary body, caused by an identifiable infectious agent. Unlike non-infectious (autoimmune or idiopathic) anterior uveitis, this form is directly triggered by bacterial, viral, fungal, or parasitic pathogens. Common infectious causes include herpes simplex virus (HSV), varicella-zoster virus (VZV), cytomegalovirus (CMV), Toxoplasma gondii, Treponema pallidum (syphilis), and Mycobacterium tuberculosis. The condition primarily affects the ocular system but may be associated with systemic infectious diseases. Patients typically present with eye pain, redness (ciliary injection), photophobia (light sensitivity), blurred vision, and tearing. On clinical examination, characteristic findings include inflammatory cells and protein flare in the anterior chamber, keratic precipitates on the corneal endothelium, and possible posterior synechiae (adhesions between the iris and lens). The presentation may be acute, recurrent, or chronic depending on the causative organism. Herpetic anterior uveitis, one of the most common infectious forms, may present with elevated intraocular pressure and characteristic iris atrophy. Treatment is directed at the underlying infectious cause and typically involves targeted antimicrobial therapy — antiviral agents (such as acyclovir or valacyclovir for herpetic uveitis), antibiotics, antifungals, or antiparasitic medications as appropriate. Topical corticosteroids are often used adjunctively to control inflammation, but must be used cautiously and only with concurrent antimicrobial coverage to avoid worsening the infection. Cycloplegic agents are employed to reduce pain and prevent synechiae formation. Early diagnosis and appropriate treatment are essential to prevent complications such as glaucoma, cataract formation, cystoid macular edema, and permanent vision loss. Prognosis varies depending on the causative organism, promptness of treatment, and whether the condition is acute or chronic.

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Infectious anterior uveitis.

View clinical trials →

No actively recruiting trials found for Infectious anterior uveitis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Infectious anterior uveitis community →

Specialists

Showing 25 of 30View all specialists →
FG
Fei Gao
WILMINGTON, NC
Specialist
1 Infectious anterior uveitis publication
MZ
Meifen Zhang
Specialist
1 Infectious anterior uveitis publication
JX
Junyan Xiao
Specialist
1 Infectious anterior uveitis publication
DL
Donghui Li
LOWELL, MA
Specialist
1 Infectious anterior uveitis publication
JK
John H Kempen
BOSTON, MA
Specialist
2 Infectious anterior uveitis publications
OO
Otto M Olivas-Vergara
Specialist
1 Infectious anterior uveitis publication
IH
Inés Hernanz
Specialist
1 Infectious anterior uveitis publication
PB
Pablo E Borges-Deniz
Specialist
1 Infectious anterior uveitis publication
FR
Fredeswinda Romero-Bueno
Specialist
1 Infectious anterior uveitis publication
OS
Olga Sanchez-Pernaute
Specialist
1 Infectious anterior uveitis publication
EC
Ester Carreño
Specialist
1 Infectious anterior uveitis publication
HS
Hang Song
BROOKLYN, NY
Specialist
1 Infectious anterior uveitis publication
CZ
Chan Zhao
Specialist
1 Infectious anterior uveitis publication
YZ
Yuelun Zhang
Specialist
1 Infectious anterior uveitis publication
YQ
Yujing Qian
Specialist
1 Infectious anterior uveitis publication
AM
Alessandro Invernizzi, MD
Specialist
PI on 1 active trial1 Infectious anterior uveitis publication
TM
Thomas Ciulla, MD
CARMEL, IN
Specialist
PI on 8 active trials
JM
John D. Sheppard, M.D.
Specialist
PI on 2 active trials
TM
Thomas Cuilla, MD, MBA
Specialist
PI on 1 active trial
BP
Brendan Johnson, PhD
Specialist
PI on 1 active trial
CF
C.Stephen Foster, MD, FACS, FACR
Specialist
PI on 1 active trial
CM
C. Stephen Foster, MD
TURNERSVILLE, NJ
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources

PREDNISOLONE ACETATE

Allergan

Uveitis

Unverified — confirm before calling
copay card
Copay CardPatient Assistance
Accepting applications

Travel Grants

No travel grants are currently matched to Infectious anterior uveitis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Infectious anterior uveitisForum →

No community posts yet. Be the first to share your experience with Infectious anterior uveitis.

Start the conversation →

Latest news about Infectious anterior uveitis

No recent news articles for Infectious anterior uveitis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Infectious anterior uveitis

What is Infectious anterior uveitis?

Infectious anterior uveitis is an inflammatory condition affecting the front portion of the uveal tract of the eye, specifically the iris and ciliary body, caused by an identifiable infectious agent. Unlike non-infectious (autoimmune or idiopathic) anterior uveitis, this form is directly triggered by bacterial, viral, fungal, or parasitic pathogens. Common infectious causes include herpes simplex virus (HSV), varicella-zoster virus (VZV), cytomegalovirus (CMV), Toxoplasma gondii, Treponema pallidum (syphilis), and Mycobacterium tuberculosis. The condition primarily affects the ocular system bu

Which specialists treat Infectious anterior uveitis?

25 specialists and care centers treating Infectious anterior uveitis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Infectious anterior uveitis?

1 patient support program are currently tracked on UniteRare for Infectious anterior uveitis. See the treatments and support programs sections for copay assistance, eligibility, and contact details.